Bazedoxifene -Treatment for Women With Schizophrenia
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To study the effect of adjunctive bazedoxifene - a selective estrogen receptor modulator
(SERM) in a double blind, placebo-controlled adjunctive study in the treatment of women with
schizophrenia. All patients receive standardized antipsychotic medication.